|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.19 EUR | +0.10% |
|
+0.43% | -1.75% |
| 06:12am | DKSH and Sanofi enter strategic partnership | RE |
| 04-14 | Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery -- Update | DJ |
| Capitalization | 97.94B 116B 90.31B 85.16B 159B 10,778B 161B 1,059B 415B 5,174B 434B 425B 18,372B | P/E ratio 2026 * |
11.9x | P/E ratio 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise value | 109B 128B 100B 94.45B 176B 11,953B 179B 1,175B 460B 5,739B 481B 471B 20,376B | EV / Sales 2026 * |
2.33x | EV / Sales 2027 * | 2.12x |
| Free-Float |
87.31% | Yield 2026 * |
5.24% | Yield 2027 * | 5.58% |
Last Transcript: Sanofi
| 1 day | +0.04% | ||
| 1 week | +0.27% | ||
| Current month | -1.91% | ||
| 1 month | +6.05% | ||
| 3 months | +0.45% | ||
| 6 months | -6.01% | ||
| Current year | -1.91% |
| 1 week | 78.83 |  | 82.39 |
| 1 month | 75.33 | | 83.77 |
| Current year | 74.85 | | 84.97 |
| 1 year | 74.85 | | 98.36 |
| 3 years | 74.85 | | 110.88 |
| 5 years | 74.85 | | 110.88 |
| 10 years | 62.5 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 16/02/2026 | |
| Director of Finance/CFO | 63 | 31/03/2024 | |
Madeleine Roach
COO | Chief Operating Officer | 41 | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 72 | 30/04/2014 |
| Director/Board Member | 60 | 29/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 27/04/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.75% | 3.66% | 158 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +0.27% | -10.23% | -20.82% | 116B | |
| -1.89% | -5.06% | +19.53% | +141.52% | 810B | |
| -0.60% | -1.09% | +55.36% | +43.92% | 575B | |
| -0.88% | -1.50% | +17.88% | +28.98% | 369B | |
| -0.35% | +0.48% | +23.57% | +13.94% | 324B | |
| +0.24% | -3.06% | +44.41% | +25.24% | 311B | |
| -1.72% | -4.29% | +50.40% | +2.25% | 291B | |
| -0.49% | -3.62% | +30.18% | +33.67% | 289B | |
| -0.78% | -0.45% | +17.92% | +39.29% | 188B | |
| -0.48% | -1.25% | +32.26% | +68.40% | 173B | |
| Average | -0.15% | -1.34% | +28.13% | +37.64% | 344.6B | |
| Weighted average by Cap. | -0.03% | -1.23% | +31.01% | +55.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 46.65B 55.07B 43.01B 40.56B 75.65B 5,133B 76.87B 504B 197B 2,464B 207B 202B 8,750B | 49.55B 58.49B 45.69B 43.08B 80.35B 5,452B 81.65B 536B 210B 2,618B 219B 215B 9,294B |
| Net income | 8.74B 10.31B 8.06B 7.6B 14.17B 961B 14.4B 94.48B 36.98B 462B 38.69B 37.88B 1,639B | 9.47B 11.18B 8.73B 8.23B 15.36B 1,042B 15.61B 102B 40.09B 500B 41.94B 41.06B 1,776B |
| Net Debt | 10.68B 12.61B 9.85B 9.29B 17.33B 1,176B 17.61B 116B 45.23B 564B 47.32B 46.33B 2,004B | 7.06B 8.33B 6.51B 6.14B 11.45B 777B 11.63B 76.33B 29.88B 373B 31.26B 30.6B 1,324B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/04/26 | 81.18 € | +0.09% | 466,636 |
| 15/04/26 | 81.11 € | +0.11% | 1,922,357 |
| 14/04/26 | 81.02 € | +2.03% | 2,385,040 |
| 13/04/26 | 79.41 € | -0.97% | 1,740,000 |
| 10/04/26 | 80.19 € | -0.90% | 2,027,807 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition